Weight-loss supplements recommended by influencers on social mead are generally ineffective for weight loss, but do have some benefits.

I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

They burst onto the scene four years ago and are taking over the pharmaceutical world. New GLP-1-based drugs like Ozempic, ...

Popular weight-loss drugs like Ozempic and Zepbound have revolutionized how we tackle obesity. But now, emerging reports ...

CVS says the decision to cover Wegovy and exclude Zepbound is "forcing the drug manufacturers to compete with one another" and will encourage both Eli Lilly and Novo Nordisk to lower prices for their ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

Some less expensive versions of popular weight loss drugs are no longer available to patients, after the Food & Drug ...

July kicks off the latter half of 2025, and the first six months of this year have been eventful, to say the least. Yet, the ...

"Employers have absorbed the majority of cost increases over the past four years, and they likely cannot continue to do so," ...